Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 28, 2020

Primary Completion Date

February 12, 2022

Study Completion Date

June 12, 2022

Conditions
Chronic Heart Failure
Interventions
DEVICE

The AquaPass System

The AquaPass device is a capsule that creates relatively homogenous temperature around the patients' lower body, while controlling and maintaining at a low percentage the relative humidity within the capsule thus enabling controlled environment that enhances sweat rate.

Trial Locations (1)

3109601

Rambam Health Care Campus, Haifa

Sponsors
All Listed Sponsors
lead

AquaPass Medical Ltd.

INDUSTRY

NCT04578353 - Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients | Biotech Hunter | Biotech Hunter